Stuart Black

470 total citations
14 papers, 342 citations indexed

About

Stuart Black is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stuart Black has authored 14 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Stuart Black's work include Hepatitis C virus research (13 papers), HIV/AIDS drug development and treatment (12 papers) and Hepatitis B Virus Studies (10 papers). Stuart Black is often cited by papers focused on Hepatitis C virus research (13 papers), HIV/AIDS drug development and treatment (12 papers) and Hepatitis B Virus Studies (10 papers). Stuart Black collaborates with scholars based in United States, Japan and Canada. Stuart Black's co-authors include Patricia McMonagle, Stephanie Curry, Janice Wahl, A Howe, Michael Robertson, Barbara Haber, Mark J. DiNubile, Paul Ingravallo, Rong Liu and Paul Y. Kwo and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Stuart Black

14 papers receiving 335 citations

Peers

Countries citing papers authored by Stuart Black

Since Specialization

Citations

This map shows the geographic impact of Stuart Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Black more than expected).

Fields of papers citing papers by Stuart Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Black. The network helps show where Stuart Black may publish in the future.

Co-authorship network of co-authors of Stuart Black

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Black. A scholar is included among the top collaborators of Stuart Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Black. Stuart Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2 2019 ·Antimicrobial Agents and Chemotherapy ·Ernest Asante‐Appiah, Paul Ingravallo, Patricia McMonagle, (unknown), Ellen Xia, Stephanie Curry, Ping Qiu, Stuart Black, Robert A. Chase, Rong Liu, Frederick Lahser	2
2	Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse 2018 ·Infection and Drug Resistance ·David Bonsall, Stuart Black, Anita Y. M. Howe, Robert A. Chase, Paul Ingravallo, (unknown), Anthony Brown, David A. Smith, Rory Bowden, Eleanor Barnes	7
3	In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A 2018 ·Antimicrobial Agents and Chemotherapy ·Ernest Asante‐Appiah, Rong Liu, Stephanie Curry, Patricia McMonagle, Sony Agrawal, Donna Carr, Laura L. Rokosz, Frederick Lahser, (unknown), Robert A. Chase, Stuart Black, Eric Ferrari, Paul Ingravallo, Ling Tong, Wensheng Yu, Joseph A. Kozlowski	4
4	Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a 2017 ·Journal of Biological Chemistry ·Zhuyan Guo, Stuart Black, Yuan Hu, Patricia McMonagle, Paul Ingravallo, Robert A. Chase, Stephanie Curry, Ernest Asante‐Appiah	8
5	HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials 2016 ·Antiviral Research ·Steven W. Ludmerer, (unknown), Stuart Black, A Howe, Wei Chang, (unknown), Keisuke Nakamura, Yoshiyuki Tanaka, Hiromitsu Kumada, Norio Hayashi, David C. Nickle	2
6	Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection 2016 ·Gastroenterology ·Paul Y. Kwo, Edward Gane, Cheng‐Yuan Peng, Brian L. Pearlman, John M. Vierling, Lawrence Serfaty, Marı́a Buti, Stephen D. Shafran, Paul Stryszak, Lin Li, Jacqueline Gress, Stuart Black, Frank J. Dutko, Michael Robertson, Janice Wahl, Lisa Lupinacci, Eliav Barr, Barbara Haber	124
7	The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study 2016 ·Journal of Gastroenterology ·Hiromitsu Kumada, Yoshiyuki Suzuki, Yoshiyasu Karino, Kazuaki Chayama, Norifumi Kawada, Takeshi Okanoue, Yoshito Itoh, Satoshi Mochida, Hidenori Toyoda, Hitoshi Yoshiji, Shintaro Takaki, (unknown), (unknown), Takashi Iwasa, Go Fujimoto, Michael Robertson, Stuart Black, Luzelena Caro, Janice Wahl	51
8	P0891 : Resistance analysis of virologic failures in Hepatitis C genotype 1 infected patients treated with grazoprevir/elbasvir +/− ribavirin: The C-worthy study 2015 ·Journal of Hepatology ·Stuart Black, (unknown), Paul Ingravallo, Patricia McMonagle, Robert A. Chase, Melissa Shaughnessy, Peggy Hwang, Barbara Haber, P. Richard Harrigan, Chanson J. Brumme, A Howe	30
9	Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir 2015 ·Antimicrobial Agents and Chemotherapy ·Rong Liu, Stephanie Curry, Patricia McMonagle, Wendy W. Yeh, Steven W. Ludmerer, Patricia Jumes, William L. Marshall, Stephanie E. Kong, Paul Ingravallo, Stuart Black, (unknown), Mark J. DiNubile, A Howe	59
10	Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection 2014 ·Clinical Infectious Diseases ·A Howe, Stuart Black, Stephanie Curry, Steven W. Ludmerer, Rong Liu, Richard J. O. Barnard, (unknown), Peggy Hwang, David C. Nickle, Christopher L. Gilbert, Luzelena Caro, Mark J. DiNubile, Niloufar Mobashery	33
11	Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin 2014 ·Open Forum Infectious Diseases ·John A. Howe, Jianmin Long, Stuart Black, Robert A. Chase, Patricia McMonagle, Stephanie Curry, Seth Thompson, Mark J. DiNubile, Anita Y. M. Howe	16
12	Generation of a Chimeric Hepatitis C Replicon Encoding a Genotype-6a NS3 Protease and Assessment of Boceprevir (SCH503034) Sensitivity and Drug-Associated Mutations 2014 ·Antiviral Therapy ·Amanda L. Aloia, Nicholas S. Eyre, Stuart Black, Stephen J. Bent, (unknown), Zhuyan Guo, Sumudu Narayana, Robert A. Chase, Stephen Locarnini, Jillian M. Carr, John A. Howe, Michael R. Beard	4
13	1197 MK-5172 IN COMBINATION WITH PEG-INTERFERON/RIBAVIRIN DEMONSTRATES ROBUST EFFICACY AND A LOW RATE OF RESISTANCE-ASSOCIATED VIROLOGIC FAILURE IN TREATMENT NAÏVE GENOTYPE 1 CHRONIC HCV-INFECTED PATIENTS 2013 ·Journal of Hepatology ·A Howe, Steven W. Ludmerer, (unknown), Stuart Black, (unknown), (unknown), (unknown), David C. Nickle, Peggy Hwang, Christopher L. Gilbert, Niloufar Mobashery	1
14	1198 HCV NS3/4A PROTEASE RESISTANCE-ASSOCIATED VARIANTS (RAVS) IDENTIFIED IN GENOTYPE 1A PATIENTS EXHIBIT DIFFERENCES IN PHENOTYPIC RESISTANCE TO BOCEPREVIR AND TELAPREVIR IN GENOTYPE 1A REPLICON CELLS 2012 ·Journal of Hepatology ·Stuart Black, Patricia McMonagle, Robert A. Chase, Stephanie Curry, Richard J. O. Barnard, Daria J. Hazuda, A Howe, John A. Howe, Robert A. Ogert	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact